Across TCGA pan-cancer cohorts, RPL7P59 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RPL7P59’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RPL7P59 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL7P59 is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.

COAD, LIHC, and KICH are the cancer types where RPL7P59 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL7P59 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	All	+0.155	.002	9	view →
LIHC	Female	All	+0.044	.018	3	view →
KICH	Female	III,IV	−0.099	.025	1	view →
KIRC	All	All	+0.033	.049	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: RPL7P59 RNA expression & survival · all RPL7P59 data types